Table 1 Demographic details of the Delphi participants in each round
From: Delphi survey to inform patient-reported symptom monitoring after ovarian cancer treatment
HCPs | Round 1 (n = 12) | Round 2 (n = 8) | |
Age | 26–45 | 5 | 4 |
46–55 | 7 | 4 | |
Gender | Male | 3 | 2 |
Female | 9 | 6 | |
Professional role | Consultant | 7 | 5 |
CNS | 5 | 3 | |
Time working in ovarian cancer | 1–5 years | 2 | 2 |
6–10 years | 6 | 4 | |
10+ years | 4 | 2 | |
Hospital site | Site 1 | 5 | 5 |
Site 2 | 2 | 1 | |
Site 3 | 2 | 1 | |
Site 4 | 3 | 1 | |
Patients | Round 1 (n = 18) | Round 2 (n = 11) | |
Age | 18–45 | 3 | 2 |
46–55 | 2 | 1 | |
56–65 | 4 | 4 | |
66–75 | 8 | 4 | |
76+ | 1 | 0 | |
How long since last treatment? | 6–12 months | 9 | 7 |
1–3 years | 9 | 4 | |
First diagnosis or relapse? | First | 14 | 7 |
Relapse | 4 | 4 | |
Hospital site | Site 1 | 7 | 4 |
Site 2 | 4 | 3 | |
Site 3 | 2 | 0 | |
Site 4 | 5 | 4 | |